Imunon, Inc. (IMNN) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 15 Form 4 transactions for Imunon, Inc. (IMNN) over the past 18 months (most recent 2026-07-07). Recent activity: Tardugno Michael H (Executive Chairman of Board) Buy 4,410 shares, Lindborg Stacy (President and CEO) Buy 2,534 shares, Eylward Susan (General Counsel and Corp Sec) Buy 920 shares, Faller Douglas Vincent (Chief Medical Officer) Buy 1,308 shares, Eylward Susan (General Counsel and Corp Sec) Sell 920 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-07Tardugno Michael HExecutive Chairman of BoardBuy4,410$8,423
2026-07-07Lindborg StacyPresident and CEOBuy2,534$4,840
2026-07-07Eylward SusanGeneral Counsel and Corp SecBuy920$1,757
2026-07-07Faller Douglas VincentChief Medical OfficerBuy1,308$2,498
2026-07-07Eylward SusanGeneral Counsel and Corp SecSell920$1,730
2026-06-23Tardugno Michael HExecutive Chairman of BoardBuy4,629$8,425
2026-06-23Lindborg StacyPresident and CEOBuy1,803$3,281
2026-06-09Tardugno Michael HExecutive Chairman of BoardBuy4,089$8,423
2026-06-09Lindborg StacyPresident and CEOBuy1,593$3,282
2025-09-09Lindborg StacyPresident and CEOBuy1,667$0
2025-08-06Braun Donald PDirectorBuy2,040$18,768
2025-08-06Fritz Frederick J.DirectorBuy3,161$29,081
2025-08-06Dentzer James EDirectorBuy3,318$30,526
2025-08-06Pellizzari Christine ADirectorBuy2,248$20,682
2025-01-28Braun Donald PDirectorBuy25,000$0

Source: SEC Form 4 filings · as of 2026-07-07